pharma · Hepatitis B, Chronic · Cancer
EmeraMed
Immunocore Ireland Limited
Immunocore Ireland is a pharma organization headquartered in GB. Primary therapeutic focus areas include Hepatitis B, Chronic, Cancer, Chronic HIV infection, Advanced PRAME Positive Cancers, Previously untreated advanced
Ranelagh, IE HQ
2007 Founded
7 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Ranelagh, IE
- Founded
- 2007
- Employees
- 7
- Programs
- 5
- Drugs
- 9
- Patents
- 0
IMC-I109V Single Ascending Dose
Phase 1 · small molecule · Hepatitis B, Chronic
IMC-I109V Single Ascending Dose for Hepatitis B, Chronic is a Phase 1 program (small_molecule) at Immunocore Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code IMC-I109V-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Immunocore Ireland Limited
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Hepatitis B, Chronic
- Status
- terminated
- Trials
- 1